NAFLD displays reduced IGF-1 levels and elevated levels of IGF-binding proteins (IGFBPs), whereas advanced fibrosis is associated with further IGF-1 decline and heightened CKD risk [139]. This evidence concerns the gene IGF1 and chronic kidney disease.